Zhang Xin, Zhao Hua, Zhu Jin, Tang Yinda, Ying Tingting, Yuan Yan, Li Shiting
Department of Neurosurgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Center for Diagnosis and Treatment of Cranial Nerve Diseases, Shanghai Jiao Tong University, Shanghai, China.
Department of Neurosurgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Center for Diagnosis and Treatment of Cranial Nerve Diseases, Shanghai Jiao Tong University, Shanghai, China.
World Neurosurg. 2017 Aug;104:186-191. doi: 10.1016/j.wneu.2017.04.048. Epub 2017 Apr 19.
Microvascular decompression (MVD) is the most useful treatment for hemifacial spasm (HFS). In cases of vertebral artery (VA) compression of the facial nerve, MVD is often difficult. In this study, we compared the outcome of the biomedical glue sling technique with the traditional technique in MVD for HFS involving the VA.
A retrospective study of patients with HFS treated by MVD was conducted between January 2013 and December 2015. A total of 327 patients with VA-associated HFS underwent their first MVD at our institution. Among them, the traditional technique was performed in 153 patients and the biomedical glue sling technique was performed in 174 patients. We measured effectiveness at 1 day, 7 days, 1 month, 3 months, and 1 year after MVD surgery.
In the traditional technique group, the effective rates of MVD were 89.54%, 88.89%, 89.40%, 88.44%, and 86.71%, and the incidence rates of complication were 5.23%, 4.58%, 3.97%, 2.72%, and 0.70%. In the biomedical glue sling technique group, the effective rates of operation were 96.55%, 96.55%, 97.66%, 95.86%, and 95.76% (P < 0.05), and the incidence rates of complication were 8.62%, 8.62%, 7.60%, 4.73%, and 2.42% (P > 0.05).
When the HFS were associated with the VA, the effective rate of biomedical glue sling technique of MVD was higher than the traditional technique, and there was no statistical difference between the 2 groups about the incidence of complication.
微血管减压术（MVD）是治疗面肌痉挛（HFS）最有效的方法。在椎动脉（VA）压迫面神经的病例中，微血管减压术往往具有难度。在本研究中，我们比较了生物医学胶水悬吊技术与传统技术在涉及椎动脉的面肌痉挛微血管减压术中的效果。
对2013年1月至2015年12月间接受微血管减压术治疗的面肌痉挛患者进行回顾性研究。共有327例与椎动脉相关的面肌痉挛患者在我院接受了首次微血管减压术。其中，153例患者采用传统技术，174例患者采用生物医学胶水悬吊技术。我们在微血管减压术后1天、7天、1个月、3个月和1年测量疗效。
在传统技术组中，微血管减压术的有效率分别为89.54%、88.89%、89.40%、88.44%和86.71%，并发症发生率分别为5.23%、4.58%、3.97%、2.72%和0.70%。在生物医学胶水悬吊技术组中，手术有效率分别为96.55%、96.55%、97.66%、95.86%和95.76%（P<0.05），并发症发生率分别为8.62%、8.62%、7.60%、4.73%和2.42%（P>0.05）。
当面肌痉挛与椎动脉相关时，微血管减压术的生物医学胶水悬吊技术有效率高于传统技术，两组并发症发生率无统计学差异。
